文献速递临床试验与 GCP基础与转化研究

经颅磁刺激联合简短认知行为疗法治疗退伍军人自杀:随机对照试验方案

Combined transcranial magnetic stimulation and brief cognitive behavioral therapy for suicide: study protocol for a randomized controlled trial in veterans.
PubMed 文献 · Trials · 2020-11-12

主要目的是检验TMS增强BCBT能否降低自杀意念、自杀尝试及其他不良治疗结局。

要点

  • TMS联合BCBT可能增强对退伍军人自杀的治疗效果。
  • 研究采用随机双盲假对照平行设计,随访至12个月。
  • 若结果阳性,可快速在VA系统内推广并直接影响退伍军人自杀。

核心结论

  • 该方案旨在检验TMS增强BCBT能否降低退伍军人自杀意念、自杀尝试及其他不良治疗结局。

研究设计与样本

  • 参与者随机接受30次每日主动或假TMS联合12周BCBT,平行组设计。
  • 在基线、治疗终点及6个月和12个月随访时完成访谈和问卷。

关键数值与推荐

  • 纳入标准为过去2周内有自杀计划或自杀行为的退伍军人。
  • 主要分析采用混合效应回归检验治疗条件对自杀行为、心理社会功能改善和精神科住院的影响。
  • 探索性潜变量增长曲线分析检验治疗效应的中介和调节因素。

临床怎么用

  • 若结果阳性,该增强治疗方案可快速在VA系统内实施,对退伍军人自杀产生直接有意义的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: At least 17 veterans die every day from suicide. Although existing treatments such as brief cognitive behavioral therapy (BCBT) have been found to reduce suicide attempts in military personnel, a number of patients go on to attempt suicide after completing therapy. Thus, finding ways to enhance treatment efficacy to reduce suicide is critical. Repetitive transcranial magnetic stimulation (TMS) is a noninvasive technique that can be used to stimulate brain regions that are impaired in suicidal patients, that has been successfully used to augment treatments for psychiatric disorders implicated in suicide. The goal of this study is to test whether augmenting BCBT with TMS in suicidal veterans reduces rates of suicidal ideation, attempts, and other deleterious treatment outcomes. METHODS: One hundred thirty veterans with a suicide plan or suicidal behavior in the prior 2 weeks will be recruited from inpatient and outpatient settings at the Providence VA Medical Center in the USA. Veterans will be randomly assigned to receive 30 daily sessions of active or sham TMS in concert with a 12-week BCBT protocol in a parallel group design. Veterans will complete interviews and questionnaires related to psychiatric symptoms, suicidal ideation and behavior, treatment utilization, and functioning during a baseline assessment prior to treatment, at treatment endpoint, and 6- and 12-month follow-ups. Primary analyses will use mixed effect regressions to examine effects of treatment condition on suicidal behaviors, improvements in psychosocial functioning, and psychiatric hospitalization. Similar models as well as exploratory latent growth curve analyses will examine mediators and moderators of treatment effects. DISCUSSION: This protocol provides a framework for designing multilayered treatment studies for suicide. When completed, this study will be the first clinical trial evaluating the efficacy of augmenting BCBT for suicide with TMS. The results of this trial will have implications for treatment of suicide ideation and behaviors and implementation of augmented treatment designs. If positive, results from this study can be rapidly implemented across the VA system and will have a direct and meaningful impact on veteran suicide. TRIAL REGISTRATION: This study was registered prior to participant enrollment with ClinicalTrials.gov NCT03952468 . Registered on May 16, 2019. TRIAL SPONSOR CONTACT: Robert O'Brien (VA Health Services R&D), robert.obrien7@va.gov.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Bozzay ML, Primack JM, Swearingen HR, et al. Combined transcranial magnetic stimulation and brief cognitive behavioral therapy for suicide: study protocol for a randomized controlled trial in veterans. Trials. 2020. PMID: 33183345. doi:10.1186/s13063-020-04870-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。